BiotechTube

Triple Negative Breast Cancer

3 competing products in clinical development for Triple Negative Breast Cancer.

Pipeline by Phase

Pre-clinical1
Phase 22

All Products (3)

ProductCompanyStageStatusHype
No drugDaiichi SankyoPre-clinicalActive
30
Tivozanib Hydrochloride + paclitaxel + PlaceboAstellas PharmaPhase 2Terminated
27
eFT508eFFECTOR TherapeuticsPhase 2Terminated
17